A study from Karolinska Institutet, published in the journal Molecular Psychiatry, offers new insights into the progression ... predicts clinically relevant cognitive decline driven by Alzheimer's ...
New research has correlated the degree to which presenilin mutations affect the enzyme’s propensity to churn out long forms of Aβ with the age at which the mutation causes both ... predicts the age of ...
The recognition of amyloid-targeted therapies in slowing Alzheimer's progression and improving cognitive ... About IGC Pharma (dba IGC): IGC Pharma is an AI-powered, clinical-stage biotechnology ...
Additionally, the Company previously announced that IGC-1C along with IGC-1A have been identified by the Company's Artificial Intelligence ("AI") model ... in slowing Alzheimer's progression.
Sep. 5, 2024 — Research discovered a unique and promising avenue for diagnosing Alzheimer's disease (AD) earlier -- by analyzing AD biomarkers in blood -- so that the impacts of dementia can be ...
